BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 2054723)

  • 21. [Focal dystonias and facial hemispasm: treatment with botulinum A toxin].
    Astarloa R; Morales B; Sánchez V; Peñafiel N; Rábano J; Oliván J; García de Yébenes J
    Arch Neurobiol (Madr); 1991; 54(5):210-7. PubMed ID: 1804035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical and psychological factors influencing the efficacy of botulinum toxin in the treatment of hemifacial spasm and blepharospasm].
    Burbaud P; Arnaud A; Burbaud A; Lagueny A
    J Fr Ophtalmol; 1995; 18(12):751-7. PubMed ID: 8745707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term treatment of involuntary facial spasms using botulinum toxin.
    Ruusuvaara P; Setälä K
    Acta Ophthalmol (Copenh); 1990 Jun; 68(3):331-8. PubMed ID: 2392912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum-A toxin in the treatment of craniocervical muscle spasms: short- and long-term, local and systemic effects.
    Dutton JJ
    Surv Ophthalmol; 1996; 41(1):51-65. PubMed ID: 8827930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of blepharospasm and facial hemispasm with botulinum toxin. Apropos of 58 injections in 22 patients].
    Elbaz D
    Ann Otolaryngol Chir Cervicofac; 1994; 111(3):141-4. PubMed ID: 7840486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of facial spasm with botulin A toxin].
    Adenis JP; Smolik I; Maes S
    J Fr Ophtalmol; 1990; 13(5):259-64. PubMed ID: 2258549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum A toxin injection in patients with blepharospasm, torticollis and hemifacial spasm.
    Berardelli A; Carta A; Stocchi F; Formica A; Agnoli A; Manfredi M
    Ital J Neurol Sci; 1990 Dec; 11(6):589-93. PubMed ID: 2081684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Botulinum toxin A in therapy of craniocervical dystonias and hemifacial spasm].
    Thill R; Költringer P; Reisecker F; Maller J; Leblhuber F
    Acta Med Austriaca; 1991; 18(5):125-9. PubMed ID: 1796725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin A in clinical medicine.
    Elston JS
    J Physiol (Paris); 1990; 84(4):285-9. PubMed ID: 2079665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.
    Brin MF; Fahn S; Moskowitz C; Friedman A; Shale HM; Greene PE; Blitzer A; List T; Lange D; Lovelace RE
    Mov Disord; 1987; 2(4):237-54. PubMed ID: 3504553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
    Ababneh OH; Cetinkaya A; Kulwin DR
    Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group.
    Berardelli A; Formica A; Mercuri B; Abbruzzese G; Agnoli A; Agostino R; Caraceni T; Carella F; De Fazio G; De Grandis D
    Ital J Neurol Sci; 1993 Jun; 14(5):361-7. PubMed ID: 8354632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Local injection treatment with botulinum toxin A in blepharospasm, Meige syndrome and hemifacial spasm. Observations in 106 patients].
    Ceballos-Baumann AO; Gasser T; Dengler R; Oertel WH
    Nervenarzt; 1990 Oct; 61(10):604-10. PubMed ID: 2274092
    [No Abstract]   [Full Text] [Related]  

  • 34. Botulinum toxin-A for the treatment of hemifacial spasm.
    Cuevas C; Madrazo I; Magallón E; Zamorano C; Neri G; Reyes E
    Arch Med Res; 1995; 26(4):405-8. PubMed ID: 8555735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum toxin in the treatment of facial dyskinesias.
    Chong PN; Ong B; Chan R
    Ann Acad Med Singap; 1991 Mar; 20(2):223-7. PubMed ID: 1883180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin.
    Kraft SP; Lang AE
    CMAJ; 1988 Nov; 139(9):837-44. PubMed ID: 3052771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blepharospasm, Meige syndrome, and hemifacial spasm: treatment with botulinum toxin.
    Mauriello JA
    Neurology; 1985 Oct; 35(10):1499-500. PubMed ID: 4033932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term results and complications of botulinum A toxin in the treatment of blepharospasm.
    Dutton JJ; Buckley EG
    Ophthalmology; 1988 Nov; 95(11):1529-34. PubMed ID: 3211461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
    Cakmur R; Ozturk V; Uzunel F; Donmez B; Idiman F
    J Neurol; 2002 Jan; 249(1):64-8. PubMed ID: 11954870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of botulinum toxin in the treatment of one hundred patients with facial dyskinesias.
    Mauriello JA; Coniaris H; Haupt EJ
    Ophthalmology; 1987 Aug; 94(8):976-9. PubMed ID: 3658375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.